New AI Tool AI-IR Could Revolutionize Insulin Resistance Detection and Cancer Prevention

A new AI tool called AI-IR could change how doctors assess insulin resistance. Developed by researchers at the University of Tokyo Hospital, it promises greater accuracy than traditional methods like BMI. The findings also suggest a link between insulin resistance and cancer risk, opening doors for better prevention strategies.

The study, led by Yuta Hiraike of the University of Tokyo Hospital, introduces AI-IR as a more precise way to detect insulin resistance. Unlike BMI, which often gives broad estimates, this model uses nine clinical parameters already collected in standard health check-ups. This makes it easy to integrate into existing screening programmes.

Insulin resistance is known to increase the risk of diabetes and heart disease. But the research also highlights its connection to cancer, suggesting that managing it could play a role in cancer prevention. The team is now exploring how genetic differences affect an individual's susceptibility to insulin resistance.

The tool's scalability means it could be widely adopted for large-scale health assessments. By identifying high-risk individuals early, targeted interventions could become more effective.

AI-IR offers a practical and accurate alternative for measuring insulin resistance. Its potential to improve cancer prevention and early diagnosis could make it a valuable addition to public health efforts. The next steps involve refining the model and studying its real-world impact on screening programmes.